Company intelligence / Profile preview

Sepio Health

Ownership: Private
Development stage: Commercial

Overview

Sepio Health has developed Kisan Kavach®, a protective wearable designed to shield farmers from the toxic effects of pesticides and insecticides. The product uses advanced materials and chemical deactivation technology to neutralize harmful agents upon contact, reducing both personal risk and environmental contamination. It is washable, reusable, ergonomic, and affordable for widespread adoption among farmers in India and developing countries[1].

Therapeutic areas: Other
Modalities: Device (protective garment with chemical deactivation technology)
Industry: Therapeutic Medical Devices

Partnerships

Sepio’s core scientific technologies originate from the Institute for Stem Cell Science and Regenerative Medicine (iBRIC-inStem), indicating an academic partnership or spinout relationship

Beyond the preview

Go deeper on Sepio Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sepio Health.

Explore the full profile